| PRECLINICAL | evidence | The role of immunohistochemistry in the study of the newborn kidney. | Thymosin beta 4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Controlled delivery of thymosin beta4 for tissue engineering and cardiac regenerative medicine. | Tbeta4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Thymosin beta4 is rapidly internalized by cells and does not induce intracellular Ca2+ elevation. | Tbeta4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Thymosin beta4 affecting the cytoskeleton organization of the myofibroblasts. | Tbeta4 | preclinical | 2012-10-01 |
| PRECLINICAL | evidence | Thymosin beta4 stabilizes hypoxia-inducible factor-1alpha protein in an oxygen-independent manner. | Tbeta4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Thymosin beta4 and cardiac protection: implication in inflammation and fibrosis. | Tbeta4 | Inflammation | 2012-10-01 |
| PRECLINICAL | evidence | Myocardial regeneration: expanding the repertoire of thymosin beta4 in the ischemic heart. | Tbeta4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Therapeutic potential of thymosin beta4 in myocardial infarct and heart failure. | Tbeta4 | Lipid & cardiovascular markers | 2012-10-01 |
| PRECLINICAL | evidence | The regenerative peptide thymosin beta4 accelerates the rate of dermal healing in preclinical animal models and in patients. | Tbeta4 | Wound healing | 2012-10-01 |
| PRECLINICAL | evidence | Neuroprotective and neurorestorative effects of thymosin beta4 treatment following experimental traumatic brain injury. | Tbeta4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Use of the cardioprotectants thymosin beta4 and dexrazoxane during congenital heart surgery: proposal for a randomized, double-blind, clinical trial. | Tbeta4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Cardiac repair with thymosin beta4 and cardiac reprogramming factors. | Thymosin beta 4 | Wound healing | 2012-10-01 |
| PRECLINICAL | evidence | NMR structural studies of thymosin alpha1 and beta-thymosins. | Thymosin beta 4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Development of an analytical HPLC methodology to study the effects of thymosin beta4 on actin in sputum of cystic fibrosis patients. | Tbeta4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Identification of interaction partners of beta-thymosins: application of thymosin beta4 labeled by transglutaminase. | Thymosin beta 4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Antibodies in research of thymosin beta4: investigation of cross-reactivity and influence of fixatives. | Thymosin beta 4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Thymosin beta4 sustained release from poly(lactide-co-glycolide) microspheres: synthesis and implications for treatment of myocardial ischemia. | Tbeta4 | — | 2012-10-01 |
| PRECLINICAL | evidence | Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. | TB 500 | — | 2012-09-01 |
| PRECLINICAL | evidence | Thymosin beta4 promotes the migration of endothelial cells without intracellular Ca2+ elevation. | Tbeta4 | preclinical | 2012-08-15 |
| PRECLINICAL | evidence | Essential role for thymosin beta4 in regulating vascular smooth muscle cell development and vessel wall stability. | Tbeta4 | — | 2012-08-03 |
| PRECLINICAL | evidence | Platelet function and thymosin beta4. | Tbeta4 | — | 2012-07-01 |
| PRECLINICAL | evidence | Nuclear Factor-kappaB: central regulator in ocular surface inflammation and diseases. | Thymosin β4 | Inflammation | 2012-07-01 |
| PRECLINICAL | evidence | Expression of thymosin beta4 in odontoblasts during mouse tooth development. | Tbeta4 | — | 2012-05-01 |
| PRECLINICAL | evidence | Thymic peptides differentially modulate human hair follicle growth. | Thymosin beta 4 | — | 2012-05-01 |
| PRECLINICAL | evidence | Rapid, non-targeted discovery of biochemical transformation and biomarker candidates in oncovirus-infected cell lines using LAESI mass spectrometry. | Thymosin beta 4 | preclinical | 2012-04-18 |
| PRECLINICAL | evidence | Proteomic analysis of primary colon cancer-associated fibroblasts using the SELDI-ProteinChip platform. | Thymosin beta 4 | Skin appearance & aging · preclinical | 2012-03-01 |
| PRECLINICAL | evidence | Evaluation of thymosin beta4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma. | Tbeta4 | Wound healing | 2012-03-01 |
| PRECLINICAL | evidence | Thymosin beta 4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial mesenchymal transition. | Tbeta4 | preclinical | 2012-02-15 |
| PRECLINICAL | evidence | How a single residue in individual beta-thymosin/WH2 domains controls their functions in actin assembly. | Thymosin β4 | — | 2012-02-15 |
| PRECLINICAL | evidence | No muscle for a damaged heart: thymosin beta 4 treatment after myocardial infarction does not induce myocardial differentiation of epicardial cells. | Thymosin beta 4 | — | 2012-01-01 |
| PRECLINICAL | evidence | The evolution of extracellular fibrillins and their functional domains. | TB4 | — | 2012-01-01 |
| PRECLINICAL | evidence | Thymosin beta4: a potential molecular target for tumor therapy. | Tbeta4 | — | 2012-01-01 |
| PRECLINICAL | evidence | MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. | Thymosin beta 4 | — | 2012-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 protein therapy for cardiac repair. | Tbeta4 | — | 2012-01-01 |
| PRECLINICAL | evidence | The epicardium as a candidate for heart regeneration. | Tbeta4 | — | 2012-01-01 |
| PRECLINICAL | evidence | Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications. | Thymosin beta 4 | — | 2012-01-01 |
| PRECLINICAL | evidence | Thymosin beta 4 is associated with collateral development in coronary artery disease. | Tbeta4 | — | 2011-12-01 |
| PRECLINICAL | evidence | Controlling charge states of peptides through inductive electrospray ionization mass spectrometry. | Thymosin beta 4 | — | 2011-12-01 |
| PRECLINICAL | evidence | Multiplexed molecular descriptors of pressure ulcers defined by imaging mass spectrometry. | Thymosin beta 4 | Wound healing | 2011-11-01 |
| PRECLINICAL | evidence | Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. | Tbeta4 | — | 2011-11-01 |
| PRECLINICAL | evidence | Thymosin beta4 activates integrin-linked kinase and decreases endothelial progenitor cells apoptosis under serum deprivation. | Tbeta4 | preclinical | 2011-11-01 |
| PRECLINICAL | evidence | Increased levels of thymosin beta4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin beta4 with other factors that are involved in inflammation and bone erosion in joints. | Tbeta4 | — | 2011-10-01 |
| PRECLINICAL | evidence | From proteomic multimarker profiling to interesting proteins: thymosin-beta(4) and kininogen-1 as new potential biomarkers for inflammatory hepatic lesions. | Thymosin beta 4 | Liver health | 2011-10-01 |
| PRECLINICAL | evidence | Interleukin-18-mediated interferon-gamma secretion is regulated by thymosin beta 4 in human NK cells. | Tbeta4 | — | 2011-10-01 |
| PRECLINICAL | evidence | Thymosin beta 4 induces colon cancer cell migration and clinical metastasis via enhancing ILK/IQGAP1/Rac1 signal transduction pathway. | Tbeta4 | — | 2011-09-28 |
| PRECLINICAL | evidence | Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes. | Thymosin beta 4 | — | 2011-09-01 |
| PRECLINICAL | evidence | Thymosin beta(4) knockdown disrupts mitochondrial functions of SW480 human colon cancer cells. | Tbeta4 | Longevity & cellular aging · preclinical | 2011-09-01 |
| PRECLINICAL | evidence | Elevated expression of thymosin beta4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1alpha in early-stage cervical cancers. | Thymosin beta 4 | — | 2011-09-01 |
| PRECLINICAL | evidence | Elevated expression of thymosin beta4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1alpha in early-stage cervical cancers. | TB4 | — | 2011-09-01 |
| PRECLINICAL | evidence | The effects of cyclic tensile strain on the organisation and expression of cytoskeletal elements in bovine intervertebral disc cells: an in vitro study. | Thymosin beta 4 | — | 2011-06-20 |